Rui Ci Medical (01526.HK) released its interim results, with a net profit attributable to shareholders of 55.941 million yuan, a decrease of 34.18% year-on-year.

Zhtng Cijng APP reports that ReLife Medical (01526.HK) has released its interim performance for the six months ending on June 30, 2025. The group generated revenue of 1.145 billion yuan, a decrease of 7% year-on-year. The profit attributable to owners of the company was 55.941 million yuan, a decrease of 34.18% year-on-year. Earnings per share were 0.04 yuan.